Announcement NervGen’s robust investigational peptide therapeutic, NVG-291, has successfully enhanced the quality of life and improved functional performance in a patient group having chronic spinal cord injury. The drug for the same has been scheduled for late-stage development. NervGen con...
Announcement From July, several biotechs were forced to spin off as existing partnerships with the FDA around proofs needed for approval signalled a reversal. As per the experts, this will put the examination and approval process in a stage of more restrictive regulatory possibility. As learned in...
Announcement The sceptical and the headlines creating a debate environment are spotting the cell and gene therapy area of late. The renewal of the efforts and that required motivation is not just warranted but very important if these therapies are close to achieving their full potential value. The...
Announcement iZafe Group has confirmed that it has signed a smart partnership deal with Vakt og Alarm. The Vakt og Alarm is one of Norway’s popular providers of alarm and safety services for the welfare and care area. Via this collaboration, Vakt og Alarm will be liable for the installation,...
Announcement After getting near the end of the tunnel with the AAVantgarde closing of the Series B financing round, AGC Biologics is preparing for a new manufacturing agreement with the biotechnology company. This will be a symbol of AGC Biologics’ brand-new advancement in the adeno-based vi...
Announcement Concept Life Sciences, a known contract research organisation (CRO) delivering to the global pharma and Life Sciences industry, has proudly declared that it showcased three new research posters at the 2025 Neuroscience in San Diego, California, during the annual meeting of the Society...
Announcement EVQLV has taken a step ahead in the AI-evolving world to accelerate its business and redefine the healthcare industry's potential values, best aligning with the tech world. The EVQL has introduced Abtique, a first and best the worth online marketplace. At this online marketplace, the ...
Announcement OS Therapies Inc., the champion in listeria-related cancer immunotherapies, is near to offshoot OS Animal Health, Inc. (OSAH) into a standalone public company to be registered on a national stock exchange to accelerate the internal business. OSAH is the company’s wholly owned an...
Announcement According to the Jefferies analysis, drugs that hold strong designations tend to pass the regulatory process more swiftly, thereby increasing their chances of success. Most of the FDA's groundbreaking designations specifically point out the report findings and priority reviews that ha...
Announcement Agios Pharmaceuticals, Inc., a marketing-level biopharmaceutical company attentive on serving the best innovative medicines for patient groups with rare diseases, have unveiled its promising top results from the long-term 52-week global RISE UP Phase 3 trial of an oral pyruvate kinase...
